Nursing Elites

1. Which of the following is a chronic lung disease that includes conditions such as chronic bronchitis and emphysema, characterized by obstructed airflow from the lungs?

• A. Chronic obstructive pulmonary disease (COPD)
• B. Pulmonary fibrosis
• C. Asthma
• D. Pneumonia

Correct answer: A

Rationale: The correct answer is A, Chronic obstructive pulmonary disease (COPD). COPD is a chronic lung disease that encompasses conditions like chronic bronchitis and emphysema. These conditions lead to obstructed airflow from the lungs, causing symptoms such as cough, shortness of breath, and wheezing. Choice B, Pulmonary fibrosis, involves scarring of the lung tissue, leading to breathing difficulties but is not specifically characterized by obstructed airflow like COPD. Asthma (Choice C) is a chronic condition characterized by airway inflammation and bronchoconstriction, not always resulting in obstructed airflow. Pneumonia (Choice D) is an acute infection of the lung tissue, causing symptoms like fever, cough, and difficulty breathing, but is not a chronic condition like COPD.

2. What is a condition where the airways become swollen and produce extra mucus, making it difficult to breathe, often associated with COPD?

• A. Chronic bronchitis
• B. Pneumonia
• C. Emphysema
• D. Tuberculosis

Correct answer: A

Rationale: Chronic bronchitis is the correct answer. It is a long-term inflammation of the bronchi, leading to persistent cough and mucus production, commonly associated with chronic obstructive pulmonary disease (COPD). Pneumonia (Choice B) is an infection that inflames the air sacs in one or both lungs. Emphysema (Choice C) is a lung condition where the air sacs in the lungs are damaged, making it difficult to breathe. Tuberculosis (Choice D) is a bacterial infection that primarily affects the lungs.

3. The client is on amiodarone and reports blurred vision. What is the nurse’s best response?

• A. Reassure the client that this is a common side effect.
• B. Instruct the client to report this symptom to the healthcare provider immediately.
• C. Advise the client to stop taking the medication.
• D. Discontinue the amiodarone immediately.

Correct answer: B

Rationale: Blurred vision is a potential side effect of amiodarone. Instructing the client to report this symptom to the healthcare provider immediately is the most appropriate response. Choice A is incorrect because although blurred vision can be a common side effect of amiodarone, it should not be dismissed without further evaluation. Choice C is incorrect as advising the client to stop taking the medication without consulting the healthcare provider can be dangerous and is not the first course of action. Choice D is too drastic as discontinuing the medication should be done under the guidance of a healthcare provider after proper evaluation.

4. When administering dobutamine to a client, what is the most important parameter to assess?

• A. Blood pressure
• B. Heart rate
• C. Oxygen saturation
• D. Respiratory rate

Correct answer: A

Rationale: When giving dobutamine, the most critical parameter to assess is blood pressure. Dobutamine is known to cause significant changes in blood pressure, making it essential to closely monitor this parameter to prevent adverse effects. While heart rate is also important to monitor, blood pressure takes precedence due to the potential for hemodynamic instability caused by dobutamine. Oxygen saturation and respiratory rate, although vital signs to monitor, are not typically affected directly by dobutamine administration.

5. The client is on warfarin and has an INR of 1.5. What is the nurse’s priority action?

• A. Increase the dose of warfarin.
• B. Hold the next dose of warfarin.
• C. Continue the current dose of warfarin.
• D. Monitor the client’s INR closely.

Correct answer: B

Rationale: An INR of 1.5 is below the therapeutic range for a client on warfarin, indicating that the client may be at risk of clot formation. The nurse's priority action should be to hold the next dose of warfarin to prevent further reduction of the INR. Increasing the dose could potentially lead to an increased risk of bleeding, and continuing the current dose may not be sufficient to bring the INR within the therapeutic range. Monitoring the client's INR closely is important but not the priority action in this scenario.

Similar Questions